Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BIOADAPTIVES, INC.

Get SEC filing alerts via email and in your feed for BIOADAPTIVES, INC.

BDPT

BIOADAPTIVES, INC.

About BIOADAPTIVES, INC.

BioAdaptives, Inc. develops, markets, and distributes natural plant, fungi, and algal-based nutraceutical products and medical devices aimed at improving health and wellness for humans and animals. Its product portfolio focuses on weight management, anti-aging, antiviral functions, and cognitive enhancement. The company employs proprietary formulations and clinical research, targeting health-conscious consumers through direct-to-consumer digital marketing, telehealth partnerships, and affiliate programs, while outsourcing manufacturing to maintain operational flexibility.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from BIOADAPTIVES, INC.

1
1
BIOADAPTIVES, INC. BioAdaptives Reports First Quarter 2026 Financial Results with Revenue Growth and Improved Net Loss

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
BIOADAPTIVES, INC. BioAdaptives Reports Minimal Revenue Growth and Increased Net Loss for Fiscal Year 2025

Via official filing (AI summary) | about 2 months ago | 0 comments

3
1
BIOADAPTIVES, INC. BioAdaptives Reports Increased Net Loss and Revenue Growth in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
BIOADAPTIVES, INC. BioAdaptives Reports Q2 2025 Revenue Increase to $3,219 Amid Ongoing Losses

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
BIOADAPTIVES, INC. BioAdaptives Reports Q1 2025 Financial Results with Net Loss of $197,136 and No Revenue

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BIOADAPTIVES, INC. BioAdaptives Reports Significant Financial Challenges, Decline in Revenue and Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments